Ittai Harel is a General Partner of Pitango. His investment's focus is in healthcare, and include Digital Health, Medical Devices, Diagnostics and Specialty Pharma.
Before joining Pitango, Ittai headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals. He also served as head of business development at IDEXX Laboratories (NASDAQ: IDXX).
Ittai currently serves on the Board of directors of Inotek Pharmaceuticals (NASDAQ: ITEK), LifeBond, EarlySense, Medisafe, Valeritas, and Vertos Medical, and serves as Chairman of the Board at LifeBond and EarlySense
Ittai holds a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, and an MBA from the MIT Sloan School of Management.